Results indicated that FSS could ameliorate learning and memory impairments and prevent neuronal injury in APP/PS1 transgenic mice that exhibit an early-onset AD-like pathology via the gut-liver-brain axis by inhibiting lipid peroxidation, decreasing levels of LPS, regulating AP activity, and regulating gut bacteria populations (Figure 8). Here, APP is linked to Alzheimer disease.